亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Prescribing Chinese patent medicines without traditional Chinese medicine training is now banned in China

        2019-09-13 06:00:00EditorGroupofTraditionalMedicineResearch
        Traditional Medicine Research 2019年5期

        Editor Group of Traditional Medicine Research

        Prescribing Chinese patent medicines without traditional Chinese medicine training is now banned in China

        Editor Group of

        Figure 1 Tong Ren Tang (600085), the market K-line

        On July 1, 2019, the website of the National Health Commission of the People’s Republic of China issued the “Notice on printing and distributing the first batch of national key monitoring and rational drugs (chemicals and biological products)” (National Health Office Medical Letter [2019] No. 558) [1], where the third article stipulates: “Other types of physicians, after not less than one year of systematically studying Chinese medicine professional knowledge and passing the examination, in accordance with the basic principles of syndrome differentiation, can issue prescriptions for Chinese patent medicine”. This mandates that Western medicine doctors in China no longer prescribe Chinese patent medicines (CPM) without completing the required training. Before the implementation of this regulation, it was common for Western medicine doctors to prescribe CPM. The market for CPM is quite large [2]. Many traditional Chinese medicine (TCM) doctors believe that Western medicine doctors who have not received specific training in TCM run the risk of incorrectly prescribing CPM [3]. In fact, the vast majority of CPM are subject to the same evaluation criteria and assessment procedures as are chemical drugs. CPM are evaluated using modern medical evaluation systems, are evaluated after they are marketed, and are subjected to standardized clinical trials rather than to evaluation using the TCM theory. Patients experiencing toxic effects from the use of TCM are found to be genetically susceptible to the effects of certain herb ingredient. For example, a recent study found that the genetic basis for susceptibility to Heshouwu (), resulting in liver damage, is the HLA-B*35:01 allele [4]. It is difficult for Western medicine doctors to identify which patients may be genetically susceptible to the toxic effects of Heshouwu (). The method of syndrome differentiation based on TCM theory has also proven to be unsuccessful in identifying this susceptibility.

        In China, Chinese and Western medicine systems are equally important, and both are held in high regard [5]. As early as the 1950s, China organized various “Western Medicine Learning TCM” classes [6] and successfully trained a group of integrated medicine physicians. At the present time, 70% of CPM are prescribed by Western medicine doctors [7]. This above-mentioned regulation restricts Western medicine doctors from prescribing CPM that patients can purchase from pharmacies, and, furthermore, compels Western medicine doctors to gain knowledge in TCM. We question whether this will result in Western medicine doctors abandoning the use of CPM. Interestingly, the stock prices of CPM companies offered in the A-share market fell after these new regulations were announced.

        :

        Editor Group of Traditional Medicine Research. Prescribing Chinese patent medicines without traditional Chinese medicine training is now banned in China. Traditional Medicine Research 2019, 4 (5): 222-223.

        1. National Health Commission of the People’s Republic of China [Internet]. Notice on printing and distributing the first batch of national key monitoring and rational drugs (chemicals and biological products). [cited 2019 July 25]. Available from: http://www.nhc.gov.cn/yzygj/s7659/201907/d356ce8a4ba1461ca66c544724dffc5e.shtml

        2. CBG [Internet]. In 2019, industry of TCM is developing rapidly and its market capacity is expanding continuously. [cited 2019 July 25]. Available from: http://free.chinabaogao.com/yiyao/201905/05541b432019.html

        3. Liu YH. Clinical compatibility of Chinese and Western medicines and analysis of irrational use of other common Chinese patent medicines. Chin Clin Ration Drug Use 2019, 12: 5-7. (Chinese)

        4. Li C, Rao T, Chen X,. HLA‐B*35:01 Allele Is a Potential Biomarker for Predicting Polygonum multiflorum–Induced Liver Injury in Humans. Hepatology, 2019, 70: 346-357.

        5. XinHua net [Internet]. White Paper-traditional Chinese medicine in China. [cited 2019 July 25]. Available from: http://www.xinhuanet.com//politics/2016-12/06/c_1120064848.htm?from=singlemessage

        6. Huang YQ. Study on the movement of Western medicine physicians learning Chinese medicine in the early period of the founding of the People's Republic of China (1955-1959). Guangzhou University of Traditional Chinese Medicine, 2006. (Chinese)

        7. National Administration of Traditional Chinese Medicine [Internet], Zhang Hongchun, member of the National Committee of the Chinese People's Political Consultative Conference: Western medicine physicians must be trained and evaluated. [cited 2019 July 25]. Available from: http://www.satcm.gov.cn/xinxifabu/gedidongtai/2019-03-05/9171.html

        10.12032/TMR20190725126

        熟妇与小伙子露脸对白| 久久国产亚洲高清观看5388| 国产91成人精品亚洲精品| 亚洲都市校园激情另类| 久久aⅴ无码av高潮AV喷| 国产自拍精品视频免费观看| 天堂一区二区三区精品| 国产视频一区二区三区在线免费| 中文字幕视频二区三区| 久久综合五月天啪网亚洲精品| 曰韩无码av一区二区免费| 国产精品v片在线观看不卡| 人妻少妇看a偷人无码精品| 日本免费人成视频播放| 亚洲国产精一区二区三区性色| av男人天堂网在线观看| 亚洲男人综合久久综合天堂| 肉色丝袜足j视频国产| 中文无码日韩欧| 国产精品香蕉在线观看| 亚洲a级片在线观看| 人妻露脸国语对白字幕| 91久久综合精品久久久综合| 国内精品久久久久久99| 亚洲亚洲人成综合网络| 人妻熟妇乱又伦精品视频app| 亚洲精品乱码久久久久久麻豆不卡 | 日韩日本国产一区二区| 美女扒开大腿让男人桶| 久久婷婷香蕉热狠狠综合| 夜夜爽无码一区二区三区| 国产精品黑丝美女av| 在线观看视频日本一区二区| 国语对白做受xxxxx在线| 亚洲欧美日韩精品高清| 911国产在线观看精品| 午夜精品人妻中字字幕| 无码精品国产一区二区三区免费| 国产99久久久国产精品免费看| 狠狠躁夜夜躁无码中文字幕| 在线观看av国产自拍|